Investigation of the reverse effect of Danhong injection on doxorubicin-induced cardiotoxicity in H9c2 cells: Insight by LC–MS based non-targeted metabolomic analysis-Reference-Cited by-同舟云学术

Investigation of the reverse effect of Danhong injection on doxorubicin-induced cardiotoxicity in H9c2 cells: Insight by LC–MS based non-targeted metabolomic analysis

Published:2018-04 Issue: Volume:152 Page:264-270
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Yi Xiaojiao,Zhu Junfeng,Zhang Jinghui,Gao Yun,Chen Zhongjian,Lu Shihai,Cai Zongwei,Hong Yanjun,Wu Yongjiang

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference24 articles.

1. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies;Octavia;J. Mol. Cell. Cardiol.,2012

2. Doxorubicin-induced cardiomyopathy;Singal;N. Engl. J. Med.,1998

3. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin;Gewirtz;Biochem. Pharmacol.,1999

4. Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity;Gu;J. Cell Mol. Med.,2015

5. Total flavonoids from Clinopodium chinense (Benth.) O. Ktze protect against doxorubicin-induced cardiotoxicity in vitro and in vivo;Chen;Evid. Based Complement. Alternat. Med.,2015

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering mechanism of Zhishi-Xiebai-Guizhi Decoction against hypoxia/reoxygenation injury in cardiomyocytes by cell metabolomics: Regulation of oxidative stress and energy acquisition;Journal of Chromatography B;2023-02

2. A review of the pharmacodynamic effect of chemo-herbal drug combinations therapy for cancer treatment;Medicine in Drug Discovery;2023-02

3. Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy;Biomedicine & Pharmacotherapy;2022-12

4. Inflammatory markers S100A8/A9 and metabolic alteration for evaluating signs of early phase toxicity of anticancer agent treatment;Food and Chemical Toxicology;2022-11

5. Systematic review of metabolomics approaches in identifying biomarkers of chemotherapy-induced cardiotoxicity among breast cancer patients;2022-09-09